NDC11 82293002210
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 82293-0022-10 | 82293-0022 |
| 82293-022-10 | 82293-022 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| pazopanib | PAZOPANIB HYDROCHLORIDE | Novugen Pharma (USA) LLC. | 25305d33-caa0-4577-8b7b-06e430c34c39 | 2024-08-19 | Boxed warning, Warnings, Adverse reactions | 82293-022-10 82293-022 82293002210 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.